How to stay relevant in pharma

Pharma marketing researchers should provide actionable recommendations to brand managers and be more proactive in identifying opportunities to research business issues, said TGaS Advisors.

Those are two areas in which pharma brand managers, surveyed by TGaS, have given marketing researchers relatively low scores, the advisory firm said.

TGaS, a unit of KnowledgePoint360, released the tips in a brief designed to help professionals ensure relevance to their organizations.

Its brief follows the State of the Industry (SOI) survey, developed and fielded in late 2011 by TGaS and the Pharmaceutical Marketing Research Group (PMRG), that found a widening chasm in the relationships between suppliers and clients, and (partly due to lower headcount) that a declining number of market researchers expects to have a big influence on commercial decision making.
You must be a registered member of MMM to post a comment.
close

Next Article in Features


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.

Email Newsletters


Pharma continues to struggle with its image. Exhibit A is the public debate around the price of, and access to, new and innovative meds. As countless transformative technologies hit market, has industry done enough to anchor its permission to innovate? To provide a closer look at trends affecting trust over the past year, MM&M presents this e-book, "The 2015 Edelman Trust Barometer." Click here.